T-Box20 suppresses oxidized low-density lipoprotein-induced human vascular endothelial cell injury by upregulation of PPAR-γ

Cellular Physiology and Biochemistry

Volumn 32, Issue 5, 2013, Pages 1137-1150

  Shen, Tao ^a   Zhu, Yuping ^a,b   Patel, Jigar ^c   Ruan, Yang ^b   Chen, Beidong ^a   Zhao, Gexin ^a   Cao, Yuan ^a   Pang, Jing ^a   Guo, Hangbang ^a   Li, Hongxia ^a   Man, Yong ^a   Wang, Shu ^a   Li, Jian ^a  

^a BEIJING HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Endothelial cell; Oxidative stress; Oxidized low density lipoprotein; T box20

Indexed keywords

ADENOVIRUS VECTOR; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CELL ADHESION MOLECULE; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; T BOX20 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; TRANSCRIPTION FACTOR TBX20;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTERY INJURY; ARTICLE; ATHEROSCLEROSIS; CELL DAMAGE; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; LIPID DIET; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; ADENOVIRIDAE; ANIMAL CELL; ANIMAL TISSUE; CELL FUNCTION; DOWN REGULATION; ENDOTHELIUM CELL; UPREGULATION; VASCULAR ENDOTHELIUM;

ADENOVIRIDAE; MUS;

ANIMALS; ATHEROSCLEROSIS; DIET, HIGH-FAT; GENE KNOCKDOWN TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LIPOPROTEINS, LDL; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; PPAR GAMMA; REACTIVE OXYGEN SPECIES; T-BOX DOMAIN PROTEINS; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84890735487     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000354514     Document Type: Article

References (34)

1. Mannarino E, Pirro M: Molecularbiologyofatherosclerosis. Clin Cases Miner Bone Metab 2008;5:57-62.
2. Mitra S, Deshmukh A, Sachdeva R, Lu J, Mehta JL: Oxidized low-density lipoprotein and atherosclerosis implications in antioxidanttherapy. Am J Med Sci2011;342:135-142.
3. Chen CH, Jiang W, Via DP, Luo S, Li TR, Lee YT, Henry PD: Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression. Circulation 2000;101:171-177.
4. Inoue M, Itoh H, Tanaka T, Chun TH, Doi K, Fukunaga Y Sawada N, Yamshita J, Masatsugu K, Saito T, Sakaguchi S, Sone M, Yamahara Ki, Yurugi T, Nakao K: Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma. Arterioscler Thromb Vase Biol 2001;21:560-566.
5. Kuzuya M, Ramos MA, Kanda S, Koike T, Asai T, Maeda K Shitara K, Shibuya M, Iguchi A: VEGF protects against oxidized LDL toxicity to endothelial cells by an intracellular glutathione-dependent mechanism through the KDR receptor. Arterioscler Thromb Vase Biol 2001;21:765-770.
6. Jovinge S, Ares MP, Kallin B, Nilsson J: Human monocytes/macrophages release TNF-alpha in response to Ox-LDL. Arterioscler Thromb Vase Biol 1996;16:1573-1579.
7. Erl W, Weber PC, Weber C: Monocytic cell adhesion to endothelial cells stimulated by oxidized low density lipoprotein is mediated by distinct endothelial ligands. Atherosclerosis 1998;136:297-303.
8. Davignon J, Ganz P: Role of endothelial dysfunction in atherosclerosis. Circulation 2004;109:11127-11132.
9. Thorin-Trescases N, Voghel G, Gendron ME, Krummen S, Farhat N, Drouin A Perrault LP, Thorin E: Pathological aging of the vascular endothelium: are endothelial progenitor cells the sentinels of the cardiovascular system? Can J Cardiol 2005;21:1019-1024.
10. Chen YH, Lin SJ, Chen YL, Liu PL, Chen JW: Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules. Cardiovasc Hematol Disord Drug Targets 2006;6:279-304.
11. Zhang J, Alcaide P, Liu L, Sun J, He A, Luscinskas FW, Shi GP: Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils. PLoS One 2011;6:el4525.
12. Takahashi M, Ikeda U, Masuyama J, Kitagawa S, Kasahara T, Shimpo M, Kano S, Shimada K: Monocyte-endothelial cell interaction induces expression of adhesion molecules on human umbilical cord endothelial cells. Cardiovasc Res 1996;32:422-429.
13. Zhu YP, Shen T, Lin YJ, Chen BD, Ruan Y, Cao Y, Qiao Y, Man Y, Wang S, Li J: Astragalus polysaccharides suppress ICAM-1 and VCAM-1 expression in TNF-α-treated human vascular endothelial cells by blocking NF-icB activation. Acta Pharmacol Sin 2013;34:1036-1042.
14. Kiefer JC: The Tbx-files: the truth is outthere. Dev Dyn 2004;231:232-236.
15. Iio A, Koide M, Hidaka K, Morisaki T: Expression pattern of novel chick T-box gene, Tbx20. Dev Genes Evol 2001;211:559-562.
16. Cai CL, Zhou W, Yang L, Bu L, Qyang Y, Zhang X, Li X, Rosenfeld MG, Chen J, Evans S: T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis. Development 2005;132:2475-2487.
17. Kraus F, Haenig B, Kispert A: Cloning and expression analysis of the mouse T-box gene tbx20. Mech Dev 2001;100:87-91.
18. Kirk ER Sunde M, Costa MW, Rankin SA, Wolstein O, Castro ML, Butler TL, Hyun C, Guo G, Otway R, Mackay IR Waddell LB, Cole AD, Hayward C, Keogh A, Macdonald R Griffiths L, Fatkin D, Sholler GF, Zorn AM, Feneley MR Winlaw DS, Harvey RP: Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am J Hum Genet 2007;81:280-291.
19. Shen T, Aneas I, Sakabe N, Dirschinger RJ, Wang G, Smemo S, Westlund JM, Cheng H, Dalton N, Gu Y, Boogerd CJ, Cai CL, Peterson K, Chen J, Nobrega MA, Evans SM: Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function. J Clin Invest 2011;121:4640-4654.
20. Sakabe NJ, Aneas I, Shen T, Shokri L, Park SY, Bulyk ML, Evans SM, Nobrega MA: Dual transcriptional activator and repressor roles of TBX20 regulate adult cardiac structure and function. Hum Mol Genet 2012;21:2194-2204.
21. Calabro R Samudio I, Safe SH, Willerson JT, Yeh ET: Inhibition oftumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-γ agonists. An in vitro study showing receptor-independent effects. J Vase Res 2005;42:509-516.
22. Hamblin M, Chang L, Fan Y, Zhang J, Chen YE: PPARs and the cardiovascular system. Antioxid Redox Signal 2009;11:1415-1452.
23. Cantini G, Lombardi A, Borgogni E, Francalanci M, Ceni E, Degl'Innocenti S Gelmini S, Poli G, Galli A, Serio M, Forti G, Luconi M: Peroxisome- proliferator-activated receptor gamma (PPARgamma) is required for modulating endothelial inflammatory response through a nongenomic mechanism. Eur J Cell Biol 2010;89:645-653.
24. Orasanu G, Ziouzenkova O, Devchand PR, Nehra V, Hamdy O, Horton ES, Plutzky J: The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice. J Am Coll Cardiol 2008;52:869-881.
25. Zieleniak A, Wojcik M, Wozniak LA: Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma. Arch Immunol Ther Exp (Warsz) 2008;56:331-345.
26. Derosa G, Maffioli P: Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists on glycemic control, lipid profile and cardiovascular risk. Curr Mol Pharmacol 2012;5:272-281.
27. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture ofhuman endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-2756.
28. Chen B, Zhao J, Zhang S, Wu W, Qi R: Aspirin inhibits the production of reactive oxygen species by downregulating Nox4 and inducible nitric oxide synthase in human endothelial cells exposed to oxidized low-densitylipoprotein. J Cardiovasc Pharmacol 2012;59:405-412.
29. Shen T, Zheng M, Cao C, Chen C, Tang J, Zhang W, Cheng H, Chen KH, Xiao RP: Mitofusin-2 is a major determinantof oxidative stress-mediated heartmuscle cell apoptosis. J Biol Chem 2007;282:23354-23361.
30. Natarajan R, Nadler JL: Lipid inflammatory mediators in diabetic vascular disease. Arterioscler Thromb Vase Biol 2004;24:1542-1548.
31. Lu Y, Qin W, Shen T, Dou L, Man Y, Wang S, Xiao C, Li J: The antioxidant N-acetylcysteine promotes atherosclerotic plaque stabilizationthrough suppression of RAGE, MMPs and NF-kappa B in ApoE-deficient mice. J Atheroscler Thromb 2011;18:998-1008.
32. Hsieh CC, Yen MH, Yen CH, Lau YT: Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells. Cardiovasc Res 2001;49:135-145.
33. Yung LM, Leung FR Yao X, Chen ZY, Huang Y: Reactive oxygen species in vascular wall. Cardiovasc Hematol Disord Drug Targets 2006;6:1-19.
34. Ray R, Shah AM: NADPH oxidase and endothelial cell function. Clin Sci (Lond) 2005;109:217-226.